Myriad Genetics (MYGN) Tops Q4 EPS by 4c
Tweet
Share
E-mail
Get Alerts MYGN Hot Sheet
Price: $4.00 -0.25%
Revenue Growth %: -7.0%
Financial Fact:
Net income: -1.2M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: -7.0%
Financial Fact:
Net income: -1.2M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Myriad Genetics (NASDAQ: MYGN) reported Q4 EPS of ($0.12), $0.04 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $177.8 million versus the consensus estimate of $169.47 million.
For earnings history and earnings-related data on Myriad Genetics (MYGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- FactSet acquires BCC Group to expand real-time market data platform
- KT&G approves KRW 360 billion share buyback and retirement plan
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
